Liver cirrhosis and decompensation still on the rise among people with hepatitis C
Is DAA treatment for hepatitis C reducing the need for liver transplants?
Tenofovir alafenamide approved for hepatitis B in Europe
People with HIV/HCV co-infection at increased risk of kidney disease and bone disorders
Almost half of MSM with HIV/HCV co-infection have HCV in their rectal fluid
Sofosbuvir-based therapy achieves excellent SVR12 rates among people who inject drugs in Ukraine
Hepatitis C virus infection is rising among gay and bisexual men in San Diego
Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice
Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people
